Our data suggest that increased bodyweight might be related to the reduced cardiotrophin-1 status, and support the view that cardiotrophin-1 may be a promising therapy for obesity. This evidence concerns the gene CTF1 and obesity due to melanocortin 4 receptor deficiency.